Gabapentin as an adjunctive treatment in bipolar disorder.
To evaluate the efficacy of gabapentin as an adjunctive treatment for bipolar disorder in both depressed and manic phases. Thirty seven patients with bipolar type I or II with or without a rapid cycling course were openly treated with gabapentin added to current treatment for up to six months. Mood symptoms were rated weekly for 12 weeks then monthly for 3 months utilizing the HamD and YMS. Participants experienced a significant reduction in both depressive and manic symptoms. These findings are consistent with others in establishing the efficacy of gabapentin in both phases of bipolar disorder. Small sample size and the use of an open uncontrolled design limit interpretation of results.